244 related articles for article (PubMed ID: 15986444)
1. Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastoma.
Grzelinski M; Bader N; Czubayko F; Aigner A
Int J Cancer; 2005 Dec; 117(6):942-51. PubMed ID: 15986444
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.
Grzelinski M; Steinberg F; Martens T; Czubayko F; Lamszus K; Aigner A
Neoplasia; 2009 Feb; 11(2):145-56. PubMed ID: 19177199
[TBL] [Abstract][Full Text] [Related]
3. Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approach.
Malerczyk C; Schulte AM; Czubayko F; Bellon L; Macejak D; Riegel AT; Wellstein A
Gene Ther; 2005 Feb; 12(4):339-46. PubMed ID: 15496960
[TBL] [Abstract][Full Text] [Related]
4. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
[TBL] [Abstract][Full Text] [Related]
5. Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth.
Czubayko F; Riegel AT; Wellstein A
J Biol Chem; 1994 Aug; 269(33):21358-63. PubMed ID: 8063762
[TBL] [Abstract][Full Text] [Related]
6. Pleiotrophin can be rate-limiting for pancreatic cancer cell growth.
Weber D; Klomp HJ; Czubayko F; Wellstein A; Juhl H
Cancer Res; 2000 Sep; 60(18):5284-8. PubMed ID: 11016659
[TBL] [Abstract][Full Text] [Related]
7. RNA interference targeting protein tyrosine phosphatase zeta/receptor-type protein tyrosine phosphatase beta suppresses glioblastoma growth in vitro and in vivo.
Ulbricht U; Eckerich C; Fillbrandt R; Westphal M; Lamszus K
J Neurochem; 2006 Sep; 98(5):1497-506. PubMed ID: 16923162
[TBL] [Abstract][Full Text] [Related]
8. Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin.
Czubayko F; Schulte AM; Berchem GJ; Wellstein A
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14753-8. PubMed ID: 8962127
[TBL] [Abstract][Full Text] [Related]
9. Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth.
Powers C; Aigner A; Stoica GE; McDonnell K; Wellstein A
J Biol Chem; 2002 Apr; 277(16):14153-8. PubMed ID: 11809760
[TBL] [Abstract][Full Text] [Related]
10. Antitumorigenic effects of a mutant of the heparin affin regulatory peptide on the U87 MG glioblastoma cell line.
Dos Santos C; Karaky R; Renoir D; Hamma-Kourbali Y; Albanese P; Gobbo E; Griscelli F; Opolon P; Dalle S; Perricaudet M; Courty J; Delbé J
Int J Cancer; 2010 Sep; 127(5):1038-51. PubMed ID: 20013808
[TBL] [Abstract][Full Text] [Related]
11. Expression of pleiotrophin, an embryonic growth and differentiation factor, in rheumatoid arthritis.
Pufe T; Bartscher M; Petersen W; Tillmann B; Mentlein R
Arthritis Rheum; 2003 Mar; 48(3):660-7. PubMed ID: 12632418
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
Nakagawara A; Milbrandt J; Muramatsu T; Deuel TF; Zhao H; Cnaan A; Brodeur GM
Cancer Res; 1995 Apr; 55(8):1792-7. PubMed ID: 7712489
[TBL] [Abstract][Full Text] [Related]
13. Phosphoproteomic analysis of the striatum from pleiotrophin knockout and midkine knockout mice treated with cocaine reveals regulation of oxidative stress-related proteins potentially underlying cocaine-induced neurotoxicity and neurodegeneration.
Vicente-Rodríguez M; Gramage E; Herradón G; Pérez-García C
Toxicology; 2013 Dec; 314(1):166-73. PubMed ID: 24096156
[TBL] [Abstract][Full Text] [Related]
14. Pleiotrophin induces formation of functional neovasculature in vivo.
Christman KL; Fang Q; Kim AJ; Sievers RE; Fok HH; Candia AF; Colley KJ; Herradon G; Ezquerra L; Deuel TF; Lee RJ
Biochem Biophys Res Commun; 2005 Jul; 332(4):1146-52. PubMed ID: 15949466
[TBL] [Abstract][Full Text] [Related]
15. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA.
Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
J Neurosurg; 2000 Feb; 92(2):297-305. PubMed ID: 10659018
[TBL] [Abstract][Full Text] [Related]
16. Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types.
Stoica GE; Kuo A; Powers C; Bowden ET; Sale EB; Riegel AT; Wellstein A
J Biol Chem; 2002 Sep; 277(39):35990-8. PubMed ID: 12122009
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo.
Ouafik L; Sauze S; Boudouresque F; Chinot O; Delfino C; Fina F; Vuaroqueaux V; Dussert C; Palmari J; Dufour H; Grisoli F; Casellas P; Brünner N; Martin PM
Am J Pathol; 2002 Apr; 160(4):1279-92. PubMed ID: 11943713
[TBL] [Abstract][Full Text] [Related]
18. Serum stimulates Pleiotrophin gene expression in an AP-1-dependent manner in human endothelial and glioblastoma cells.
Poimenidi E; Hatziapostolou M; Papadimitriou E
Anticancer Res; 2009 Jan; 29(1):349-54. PubMed ID: 19331172
[TBL] [Abstract][Full Text] [Related]
19. Differential induction of glioblastoma migration and growth by two forms of pleiotrophin.
Lu KV; Jong KA; Kim GY; Singh J; Dia EQ; Yoshimoto K; Wang MY; Cloughesy TF; Nelson SF; Mischel PS
J Biol Chem; 2005 Jul; 280(29):26953-64. PubMed ID: 15908427
[TBL] [Abstract][Full Text] [Related]
20. Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch.
Zhang N; Zhong R; Perez-Pinera P; Herradon G; Ezquerra L; Wang ZY; Deuel TF
Biochem Biophys Res Commun; 2006 May; 343(2):653-8. PubMed ID: 16554021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]